Submit Deal

FRESENIUS KABI

Summary

Fresenius Kabi is a healthcare company specializing in lifesaving medicines and technologies for critically and chronically ill patients, including intravenous (IV) drugs, clinical and medical nutrition, and infusion and transfusion technologies.

Deals Overview

Total Deals4

Valued Deals3

Total Value£ 586 M

Avg. Deal Size£ 195 M

Market Context

Senior Management

John Ducker
CEO
Steven J. Adams
CFO

Sort

31 Mar 2022|United States|Health Care Services

Target: IVENIX

Bidder: FRESENIUS KABI

3 Service Providers

1 Target | 2 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 183 M

Value

31 Mar 2022|Spain|Biotechnology

Target: MABXIENCE

Bidder: FRESENIUS KABI

5 Service Providers

1 Target | 3 Bidder | 1 Vendor

13 Dealmakers

1 Target | 9 Bidder | 3 Vendor

£ 394 M

Value

05 Jul 2022|Germany|Pharmaceuticals

Target: FRESENIUS KABI

Bidder: FAGRON NV

5 Service Providers

2 Target | 3 Bidder

20 Dealmakers

10 Target | 10 Bidder

n/a

Value

28 Jul 2022|Indonesia|Health Care Services

Target: PT ETHICA INDUSTRI FARMASI

Bidder: PT PYRIDAM FARMA TBK

2 Service Providers

2 Vendor

£ 9 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy